Literature DB >> 26081139

Genetic Variations of Kinase Inserts Domain Receptor (KDR) Gene Are Associated with the Risk of Astrocytomas.

Yufei Gao1, Piyong Ma2, Yichun He1, Yan Liu1, Yang Jiang3.   

Abstract

Astrocytomas is one of the most common central nervous system (CNS) tumors with high mortality rate. Kinase insert domain receptor (KDR) is involved in the regulation of tumor angiogenesis, migration, and vascular permeability. The aim of the study was to explore the relationship between KDR polymorphisms and risk of astrocytomas. Blood samples were collected from 157 astrocytomas patients and 160 healthy controls. Three tag-SNPs (rs2071559C/T, rs2305948T/C, and rs1870377A/T) were identified from the International HapMap Project Databases and genotyped using the method of polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). We evaluated the astrocytomas risk caused by individual SNPs and haplotype using odds ratios (ORs) and their 95 % confidence intervals (CIs). In the overall individual SNP analysis, the C allele of rs2071559 was correlated with an increased risk of astrocytomas. However, individuals with mutant allele A and genotype TA + AA of rs1870377 showed a protective effect against astrocytomas. Subgroup analysis based on WHO tumor grade revealed that the C allele of rs2071559 had more influence with the risk of astrocytomas in the grade III-IV (OR = 1.91) subgroup than the grade I-II (OR = 1.47) group. Genotype TT of rs2305948 was found to be significantly associated with susceptibility of astrocytomas only in the grade III-IV subgroup. The protective effect of rs1870377 did not reveal significant difference between the grade III-IV and grade I-II subgroups. Meanwhile, stratified analysis demonstrated that mutation of rs2071559 and rs2305948 could elevate the risk of astrocytomas more significantly in the subgroup of smokers than the nonsmokers. Interestingly, the protective effect of rs1870377 was more obvious in the nonsmokers than the smokers. Additionally, haplotype-specific analysis showed that haplotype CCT and CTT were related with an increased risk of astrocytomas. We found that individual with variants of rs2071559*C and rs2305948*T might significantly elevate the risk of astrocytomas, while mutants of rs1870377*A was associated with the decreased risk of astrocytomas. Further studies about ethnically diverse populations with larger sample size should be performed to confirm the correlation between KDR gene polymorphisms and risk of astrocytomas.

Entities:  

Keywords:  Astrocytomas; Genetic association; Haplotype; KDR; Single nucleotide polymorphisms

Mesh:

Substances:

Year:  2015        PMID: 26081139     DOI: 10.1007/s12035-015-9239-6

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  54 in total

1.  Cyclin I correlates with VEGFR-2 and cell proliferation in human epithelial ovarian cancer.

Authors:  Marek Cybulski; Bożena Jarosz; Andrzej Nowakowski; Witold Jeleniewicz; Przemysław Seroczyński; Magdalena Mazurek-Kociubowska
Journal:  Gynecol Oncol       Date:  2012-07-05       Impact factor: 5.482

2.  Association of age-related macular degeneration with polymorphisms in vascular endothelial growth factor and its receptor.

Authors:  Alessandro Galan; Alberto Ferlin; Luigi Caretti; Genny Buson; Giovanni Sato; Anna Chiara Frigo; Carlo Foresta
Journal:  Ophthalmology       Date:  2010-05-14       Impact factor: 12.079

3.  AXIN2 polymorphism and its association with astrocytoma in a Turkish population.

Authors:  Emine Gulsen Gunes; Ergun Pinarbasi; Hatice Pinarbasi
Journal:  Mol Med Rep       Date:  2010 Jul-Aug       Impact factor: 2.952

4.  Vascular endothelial growth factor receptor 2 (VEGFR-2) signalling activity in paediatric pilocytic astrocytoma is restricted to tumour endothelial cells.

Authors:  A H Sikkema; E S J M de Bont; G Molema; A Dimberg; P J Zwiers; S H Diks; E W Hoving; W A Kamps; M P Peppelenbosch; W F A den Dunnen
Journal:  Neuropathol Appl Neurobiol       Date:  2011-08       Impact factor: 8.090

Review 5.  Genetic advances in glioma: susceptibility genes and networks.

Authors:  Yanhong Liu; Sanjay Shete; Fay Hosking; Lindsay Robertson; Richard Houlston; Melissa Bondy
Journal:  Curr Opin Genet Dev       Date:  2010-03-06       Impact factor: 5.578

6.  Possible association between polymorphisms of human vascular endothelial growth factor A gene and susceptibility to glioma in a Chinese population.

Authors:  Rui Li; Yao Zhao; Weiwei Fan; Hongyan Chen; Yuanyuan Chen; Yanhong Liu; Gong Chen; Keke Zhou; Fengping Huang; Ying Mao; Liangfu Zhou; Daru Lu; Yin Yao Shugart
Journal:  Int J Cancer       Date:  2011-01-01       Impact factor: 7.396

Review 7.  Epidemiology of brain tumors.

Authors:  James L Fisher; Judith A Schwartzbaum; Margaret Wrensch; Joseph L Wiemels
Journal:  Neurol Clin       Date:  2007-11       Impact factor: 3.806

Review 8.  Molecular mechanisms of lymphangiogenesis in health and disease.

Authors:  Kari Alitalo; Peter Carmeliet
Journal:  Cancer Cell       Date:  2002-04       Impact factor: 31.743

9.  Autocrine regulation of glioblastoma cell cycle progression, viability and radioresistance through the VEGF-VEGFR2 (KDR) interplay.

Authors:  Petra Knizetova; Jiri Ehrmann; Alice Hlobilkova; Iveta Vancova; Ondrej Kalita; Zdenek Kolar; Jiri Bartek
Journal:  Cell Cycle       Date:  2008-08-12       Impact factor: 4.534

10.  Association study between of Tie2/angiopoietin-2 and VEGF/KDR pathway gene polymorphisms and vascular malformations.

Authors:  Qiupeng Zheng; Jing Du; Zhaofeng Zhang; Jianhua Xu; Lingyuan Fu; Yunlei Cao; Xianliang Huang; Lingli Guo
Journal:  Gene       Date:  2013-04-06       Impact factor: 3.688

View more
  3 in total

1.  Expanded molecular profiling of myxofibrosarcoma reveals potentially actionable targets.

Authors:  Ellen Heitzer; Sandra Sunitsch; Magdalena M Gilg; Birgit Lohberger; Beate Rinner; Karl Kashofer; Nicole Stündl; Peter Ulz; Joanna Szkandera; Andreas Leithner; Bernadette Liegl-Atzwanger
Journal:  Mod Pathol       Date:  2017-08-04       Impact factor: 7.842

2.  Association of the VEGFR2 single nucleotide polymorphism rs2305948 with glioma risk.

Authors:  Shushu Sun; Xiaotian Li; Bingkun Qu; Kunming Xie; Jinlei Li; Junjie Miao
Journal:  Medicine (Baltimore)       Date:  2022-01-07       Impact factor: 1.889

3.  Molecular Heterogeneity of Ewing Sarcoma as Detected by Ion Torrent Sequencing.

Authors:  Nana Zhang; Haijing Liu; Guanjun Yue; Yan Zhang; Jiangfeng You; Hua Wang
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.